« previous next »
Pages: [1]

Author Topic: NF2 clinical trial at MGH  (Read 14620 times)

Susan A

  • Full Member
  • ***
  • Posts: 111
NF2 clinical trial at MGH
« on: November 11, 2016, 01:53:59 pm »
Dr Plotkin at Mass General Hospital is starting a new Phase 2 clinical trial for people with NF2. The goal of this clinical research study is to learn if the study drug AZD2014 can shrink growing or symptomatic meningiomas.
Logged
2011 8 x 7 mm AN, & 20 x 22 mm M found, both on the left. Mosaic NF2 diagnosed. Some hearing loss
2014 hearing 30% on left, now using hearing aid (HA)
2015 Now have CROS HA - no longer hear enough for HA to be useful in AN ear
2016 Use an FM system on occasion at work to supplement HA

mwatto

  • Hero Member
  • *****
  • Posts: 504
Re: NF2 clinical trial at MGH
« Reply #1 on: July 22, 2021, 12:42:58 am »
Logged
Michele
20 x19x14mm Cystic AN diagnosed Feb 2019. CK.
Mri 2019 shrinking: 18x17x13 mm.
Mri 2020 - no cysts visible, stable.
MRI 2021, 2022 - stable no change
MRI 2023 Further reduction 12x12x10mm!! Hearing 87%
MRI 2024, 2025: No change in AN size or hearing status.
Pages: [1]
« previous next »